N@N

NIB, OMER, EPI, SEF, DRW, TVE Are Seasonally Ripe To Go Down In the Next Five Weeks

^{Published on 2016-10-24 01:45:52 - WOPRAI}
 

October 24, 2016 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net is monitoring the Seasonality of iPath Dow Jones-AIG Cocoa Total Return Sub-IndexSM ETN (NYSE:NIB), Omeros Corporation (NASDAQ:OMER), WisdomTree India Earnings Fund ETF (NYSE:EPI), ProShares Short Financials (NYSE:SEF), WisdomTree International Real Estate Fund (NYSE:DRW), Tennessee Valley Authority (NYSE:TVE) and each have a high seasonal probability to go Down in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. buyins.net is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:

The following stocks are expected to go Down:

  Symbol  Company                          Expected Return  Odds                 By The Following Date
  NIB     iPath Dow Jones-AIG Cocoa Total Return Sub-IndexSM ETN  -3.60%           87.50% (7 of 8)      Tuesday, November 8th 2016
  OMER    Omeros Corporation               -1.99%           100.00% (7 of 7)     Tuesday, October 25th 2016
  EPI     WisdomTree India Earnings Fund ETF  -6.63%           87.50% (7 of 8)      Friday, November 18th 2016
  SEF     ProShares Short Financials       -4.40%           87.50% (7 of 8)      Friday, December 2nd 2016
  DRW     WisdomTree International Real Estate Fund  -3.44%           88.89% (8 of 9)      Wednesday, November 16th 2016
  TVE     Tennessee Valley Authority       -1.40%           76.47% (13 of 17)    Thursday, October 27th 2016

Omeros Corporation (NASDAQ:OMER) - Omeros Corporation, a biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. It markets OMIDRIA for use during cataract surgery or intraocular lens replacement. The company s clinical products include OMS721 that is in Phase III clinical trials for the treatment of atypical hemolytic uremic syndrome; and in Phase II clinical trials for the treatment of thrombotic microangiopathies, IgA nephropathy, and other renal diseases. Its clinical programs also comprise OMS824, which is in Phase II clinical trials for the treatment of schizophrenia and Huntington's diseases; OMS405 that is in Phase II clinical trials for the treatment of opioid and nicotine addiction; and OMS201, which is in Phase I/II clinical trials for use during urological procedures. The company s preclinical programs include OMS527 for the treatment of addiction and compulsive disorders, as well as for movement disorders, such as Parkinson's disease; OMS616 to control surgical and traumatic bleeding; and OMS906 for the treatment of paroxysmal nocturnal hemoglobinuria and other alternative pathway disorders. Its preclinical programs also comprise GPR17 for the treatment of demyelinating disorders; GPR101 for appetite and eating disorders; GPR151 for the treatment of neuropathic pain and cognition; GPR161 for triple-negative breast cancer treatment; GPR174 for dysfunction of regulatory T-cell modulation; GPR183 for the treatment of osteoporosis and EBV-related diseases; and GPCR and Antibody Platform for CNS, metabolic, CV, oncologic, musculoskeletal, and other disorders. In addition, the company is developing OMS103 that has completed Phase III clinical trials for arthroscopic anterior cruciate ligament reconstruction and arthroscopic partial meniscectomy. Omeros Corporation was incorporated in 1994 and is based in Seattle, Washington..

WisdomTree India Earnings Fund ETF (NYSE:EPI) - Wisdomtree India Earnings Fund Etf.

ProShares Short Financials (NYSE:SEF) - Short Financials ProShares.

WisdomTree International Real Estate Fund (NYSE:DRW) - WisdomTree International Real Estate Sector Fund.

Tennessee Valley Authority (NYSE:TVE) - Tennessee Valley Authority engages in the production and sale of electricity in the United States. It generates power from coal-fired, nuclear, hydroelectric facilities, and combustion turbine and diesel generators. The company sells power at wholesale to distributor customers comprising municipalities and cooperatives that resell the power to their customers at a retail rate. It also supplies power directly to federal agencies and customers with large or unusual loads, as well as customers with whom it has entered into exchange power arrangements. As of September 30, 2008, it operated various power generating facilities, including 29 conventional hydroelectric sites, 1 pumped storage hydroelectric site, 11 coal-fired sites, 3 nuclear sites, 11 combustion turbine sites, 2 diesel generator sites, 1 wind energy site, 1 digester gas site, 1 biomass cofiring site, and 15 solar energy sites. The company supplies power in Tennessee, northern Alabama, northeastern Mississippi, and southwestern Kentucky and in portions of northern Georgia, western North Carolina, and southwestern Virginia to approximately nine million customers. It also manages the Tennessee River and its tributaries for various river-system purposes, such as navigation; flood damage reduction; power generation; environmental stewardship; shoreline use; and water supply for power plant operations, consumer use, recreation, and industry. The company was founded in 1931 and is based in Knoxville, Tennessee..

About BUYINS.NET

BUYINS.NET, http://www.buyins.net, monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market-maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS Friction Factor - Market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements" Naked Shorts (RegSho) - Tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING Earnings - Predicts probability, price move and length of move before and after all US stock earnings reports Seasonality - Predicts probability, price move and length of move based on exact time of year for all US stocks Group Correlation - Tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups SqueezeTrigger - Massive database that tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock. Valuation - Tracks all known valuation models and applies them. GATS - Tracks and quantifies known trading strategies by backtesting, optimizing and running genetic algorithms and neural networks to ascertain best trading strategies. PatternScan - Automates tracking of every technical pattern and predicts next move in stocks. Insider - Tracks insiders trading records and determines trading performance. Trades by higher-level insiders are generally more predictive than trades by lower level insiders Events - Tracks patterns directly correlated to specific events.

SqueezeTrigger is a registered trademark, Reg. No. 3,120,641

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. [symbol] has not approved the statements made in this release. Please read our report and visit our web site, http://www.buyins.net, for complete risks and disclosures.

Contact: BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net http://www.buyins.net